Tau is essential to β-amyloid-induced neurotoxicity M Rapoport, HN Dawson, LI Binder, MP Vitek, A Ferreira Proceedings of the National Academy of Sciences 99 (9), 6364-6369, 2002 | 1198 | 2002 |
Advanced glycation end products contribute to amyloidosis in Alzheimer disease. MP Vitek, K Bhattacharya, JM Glendening, E Stopa, H Vlassara, R Bucala, ... Proceedings of the National Academy of Sciences 91 (11), 4766-4770, 1994 | 1109 | 1994 |
Nitric oxide and redox mechanisms in the immune response DA Wink, HB Hines, RYS Cheng, CH Switzer, W Flores-Santana, ... Journal of leukocyte biology 89 (6), 873-891, 2011 | 893 | 2011 |
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. D Goldgaber, HW Harris, T Hla, T Maciag, RJ Donnelly, JS Jacobsen, ... Proceedings of the National Academy of Sciences 86 (19), 7606-7610, 1989 | 791 | 1989 |
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology RA Rissman, WW Poon, M Blurton-Jones, S Oddo, R Torp, MP Vitek, ... The Journal of clinical investigation 114 (1), 121-130, 2004 | 686 | 2004 |
Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice HN Dawson, A Ferreira, MV Eyster, N Ghoshal, LI Binder, MP Vitek Journal of cell science 114 (6), 1179-1187, 2001 | 628 | 2001 |
Solution NMR studies of the Aβ (1− 40) and Aβ (1− 42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation L Hou, H Shao, Y Zhang, H Li, NK Menon, EB Neuhaus, JM Brewer, ... Journal of the American Chemical Society 126 (7), 1992-2005, 2004 | 622 | 2004 |
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease BD Zipser, CE Johanson, L Gonzalez, TM Berzin, R Tavares, CM Hulette, ... Neurobiology of aging 28 (7), 977-986, 2007 | 560 | 2007 |
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. AL Schwarzman, L Gregori, MP Vitek, S Lyubski, WJ Strittmatter, ... Proceedings of the National Academy of Sciences 91 (18), 8368-8372, 1994 | 535 | 1994 |
Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD CA Colton, RT Mott, H Sharpe, Q Xu, WE Van Nostrand, MP Vitek Journal of neuroinflammation 3, 1-12, 2006 | 502 | 2006 |
Mechanisms of the antioxidant effects of nitric oxide DA Wink, KM Miranda, MG Espey, RM Pluta, SJ Hewett, C Colton, M Vitek, ... Antioxidants and redox signaling 3 (2), 203-213, 2001 | 479 | 2001 |
APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response JR Lynch, W Tang, H Wang, MP Vitek, ER Bennett, PM Sullivan, ... Journal of Biological Chemistry 278 (49), 48529-48533, 2003 | 456 | 2003 |
APOE genotype-specific differences in the innate immune response MP Vitek, CM Brown, CA Colton Neurobiology of aging 30 (9), 1350-1360, 2009 | 391 | 2009 |
Tau protein is required for amyloid β-induced impairment of hippocampal long-term potentiation OA Shipton, JR Leitz, J Dworzak, CEJ Acton, EM Tunbridge, F Denk, ... Journal of Neuroscience 31 (5), 1688-1692, 2011 | 385 | 2011 |
Vascular endothelial growth factor rescues hippocampal neurons from glutamate‐induced toxicity: signal transduction cascades H Matsuzaki, M Tamatani, A Yamaguchi, K Namikawa, H Kiyama, ... The FASEB Journal 15 (7), 1218-1220, 2001 | 341 | 2001 |
Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53 A Yamaguchi, M Tamatani, H Matsuzaki, K Namikawa, H Kiyama, ... Journal of Biological Chemistry 276 (7), 5256-5264, 2001 | 308 | 2001 |
Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(carboxymethyl) lysine and hexitol-lysine RJ Castellani, PLR Harris, LM Sayre, J Fujii, N Taniguchi, MP Vitek, ... Free Radical Biology and Medicine 31 (2), 175-180, 2001 | 281 | 2001 |
Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease DM Wilcock, MP Vitek, CA Colton Neuroscience 159 (3), 1055-1069, 2009 | 260 | 2009 |
Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and-independent pathways LA Ridnour, AN Windhausen, JS Isenberg, N Yeung, DD Thomas, ... Proceedings of the National Academy of Sciences 104 (43), 16898-16903, 2007 | 245 | 2007 |
Tau–an inhibitor of deacetylase HDAC6 function M Perez, I Santa‐Maria, EG De Barreda, X Zhu, R Cuadros, JR Cabrero, ... Journal of neurochemistry 109 (6), 1756-1766, 2009 | 226 | 2009 |